Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4653285

C=Cc1cc[n+](CCCC)cc1.[Cl-]

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.41
CHRM2 known ✓ P08172 1/20 0.41
CHRM1 known ✓ P11229 1/20 0.41
SLC6A2 known ✓ P23975 1/20 0.41
SLC6A3 known ✓ Q01959 1/20 0.41
HTT P42858 3/20 0.49
MEN1 O00255 3/20 0.49
MAPT P10636 3/20 0.49
KMT2A Q03164 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MAPK1 P28482 2/20 0.49
APAF1 O14727 1/20 0.49
HSP90AA1 P07900 1/20 0.49
BLM P54132 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4653273 0.98 HTT (0.50) HTTMEN1MAPTKMT2ASMN1; SMN2
Bromide SCHEMBL1674572 0.96 HTT (0.53) HTTMEN1MAPTKMT2ASMN1; SMN2
Water SCHEMBL11152895 0.94 HTT (0.51) HTTMEN1MAPTKMT2ASMN1; SMN2
Styrene SCHEMBL11152937 0.93 TSHR (0.48) HTTMEN1MAPTKMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL8027797 0.92 KMT2A (0.60) HTTMEN1MAPTKMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL9614521 0.92 KMT2A (0.60) HTTMEN1MAPTKMT2ASMN1; SMN2
Styrene SCHEMBL11147974 0.91 RAD52 (0.49) HTTMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL2786767 0.90 KMT2A (0.62) HTTMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL3392127 0.90 KMT2A (0.62) HTTMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL588400 0.90 KMT2A (0.62) HTTMEN1MAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404305-B1 PHARMACOLOGICAL PREPARATION MADE FROM A NANOPARTICULATE MESOMORPHOUS POLYELECTROLYTE LIPID COMPLEX AND AT LEAST ONE ACTIVE INGREDIENT FRAUNHOFER GES FORSCHUNG (DE) 2008-11-12 EP claimed
US-20040213834-A1 Pharmacological preparation made from a nanopatriculate mesomorphous polyelectrolyte lipid complex and at least one active ingredient FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2004-10-28 US claimed
EP-1404305-A1 PHARMACOLOGICAL PREPARATION MADE FROM A NANOPARTICULATE MESOMORPHOUS POLYELECTROLYTE LIPID COMPLEX AND AT LEAST ONE ACTIVE INGREDIENT Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2004-04-07 EP claimed
WO-2003004004-A1 PHARMACOLOGICAL PREPARATION MADE FROM A NANOPARTICULATE MESOMORPHOUS POLYELECTROLYTE LIPID COMPLEX AND AT LEAST ONE ACTIVE INGREDIENT Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2003-01-16 WO claimed
JP-5258607-A None JP disclosed
CN-118221850-A Synthesis method of low-viscosity poly alpha olefin synthetic oil by taking recyclable magnetic nano particles loaded with ionic liquid as catalyst 中海油天津化工研究设计院有限公司 2024-06-21 CN disclosed
US-20040213834-A1 Pharmacological preparation made from a nanopatriculate mesomorphous polyelectrolyte lipid complex and at least one active ingredient FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2004-10-28 US disclosed
EP-1404305-A1 PHARMACOLOGICAL PREPARATION MADE FROM A NANOPARTICULATE MESOMORPHOUS POLYELECTROLYTE LIPID COMPLEX AND AT LEAST ONE ACTIVE INGREDIENT Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2004-04-07 EP disclosed
WO-2003004004-A1 PHARMACOLOGICAL PREPARATION MADE FROM A NANOPARTICULATE MESOMORPHOUS POLYELECTROLYTE LIPID COMPLEX AND AT LEAST ONE ACTIVE INGREDIENT Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2003-01-16 WO disclosed
JP-H05258607-A ION CONDUCTIVE POLYMER COMPOUND YUASA CORP 1993-10-08 JP disclosed